BOSTON–In a move set to reshape Quincy Center’s economic landscape, Related Beal has announced a $30 million investment to convert a portion of Presidents Place into a state-of-the-art life science hub—beginning with antibody discovery firm Abveris relocating its headquarters and labs to the site.
The development marks a significant expansion of the Red Line’s life science corridor, which already includes biotech powerhouses in Cambridge’s Kendall Square and South Boston. With Quincy now joining the innovation pipeline, the corridor extends even further south—creating new opportunities for cutting-edge research and economic growth.
Biotech Meets Transit-Oriented Urban Living
Located at 1250 Hancock Street directly across from the Quincy Center MBTA stop, Presidents Place is a 350,000+ square foot mixed-use building co-owned by Boston Andes Capital. The building has served commercial, educational, and medical office tenants, and now, with Related Beal’s conversion of 75,000 square feet for lab space, it begins a new chapter in biotechnology.
“This is more than just a real estate development—it’s a strategic expansion of Greater Boston’s life sciences ecosystem,” said Stephen Faber, Executive Vice President at Related Beal. “Transit access, urban amenities, and Quincy’s vibrant downtown make Presidents Place an ideal home for innovative companies like Abveris.”
Abveris Leads the Charge
Abveris, a contract research organization that supports preclinical drug development, will be the first life sciences tenant at Presidents Place, leasing 22,000 square feet for its headquarters and laboratories. The company’s CEO, Tracey Mullen, a Quincy resident herself, emphasized the potential for biotech in the city.
“Relocating to a forward-thinking city like Quincy will support the continued growth of our organization while attracting top Boston-area talent,” said Mullen. “We are thrilled to lead the charge in bringing biotech to Quincy.”
The lease agreement was brokered by global real estate firm JLL, representing both Related Beal and Abveris.
Quincy Center has seen an economic and physical revitalization in recent years, with nearly $1 billion invested in new housing, commercial development, and green spaces. With approximately 4,000 new housing units built and 600 more on the way, the city is increasingly positioned as an ideal live-work destination.
Mayor Thomas Koch praised the announcement as a milestone in Quincy’s growth.
“This kind of investment that attracts thriving, innovative life sciences firms like Abveris is a great cornerstone for downtown’s continued economic growth,” said Mayor Koch. “Related Beal has been a valued partner in our downtown revitalization efforts, and this project continues that momentum.”
A Growing Life Sciences Portfolio
Related Beal is a prominent player in Boston’s booming life sciences real estate market. In addition to the Presidents Place project, the firm is currently developing or repositioning several key lab and innovation spaces across Greater Boston:
- iSQ: A 394,000-square-foot life science campus in South Boston’s Raymond L. Flynn Marine Park (RLFMP)
- 451 D Street: A 486,000-square-foot lab conversion in South Boston
- Innovation and Design Building: A 1.4-million-square-foot redevelopment with Jamestown Investments
- One Kenmore Square: A major project including new lab space in Boston’s Fenway area
- Channelside: A transformative, mixed-use waterfront development featuring lab, office, residential, and retail components
With Abveris anchoring the initial phase, Related Beal’s vision for Presidents Place includes long-term repositioning to attract additional life science firms. As Boston’s biotech influence continues to ripple outward, Quincy is now poised to become a key player in the region’s innovation economy.
